Despite being the second most common haematologic cancer globally, treatment options for multiple myeloma remain limited, with a significant need for new therapies. 1 Multiple myeloma originates i ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

Hyderabad: Dr Reddy's Laboratories SA, a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. has announced that it has ...

Inobrodib is being tested in relapsed/refractory multiple myeloma, a disease treated in advanced stages by B-cell maturation antigen (BCMA) targeting CAR-Ts such as Bristol-Myers Squibb’s Abecma ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Early treatment with intravenous bisphosphonates at first radiographic evidence of bone lesions in patients with solid tumors or evidence of osteopenia in patients with multiple myeloma can ...

A recombinant anti-CD38 fully human monoclonal antibody injection, HLX15 comes in both intravenous and subcutaneous formulations. Henlius will oversee development, manufacturing a ...

She spent part of the 2024 season away from the team after her mother, Jan, died in June following a two-year battle with advanced multiple myeloma. On the court, her role changed significantly as ...

A breakthrough CAR-T cell therapy, Qartemi, has been approved for blood cancer patients in India, offering new hope to those ...

With this acquisition, LipoVation becomes a wholly owned subsidiary of Revium Rx, aligning with the company’s renewed commitment to drug delivery innovation. Revium Rx is developing a portfolio of ...